Case Reports in Cardiology (Jan 2014)

Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device

  • Geetanjali Dang,
  • Ryan Grayburn,
  • Geoffrey Lamb,
  • Adrian Umpierrez De Reguero,
  • Nunzio Gaglianello

DOI
https://doi.org/10.1155/2014/826453
Journal volume & issue
Vol. 2014

Abstract

Read online

HeartWare is a third generation left ventricular assist device (LVAD), widely used for the management of advanced heart failure patients. These devices are frequently associated with a significant risk of gastrointestinal (GI) bleeding. The data for the management of patients with LVAD presenting with GI bleeding is limited. We describe a 56-year-old lady, recipient of a HeartWare device, who experienced recurrent GI bleeding and was successfully managed with subcutaneous (SC) formulations of octreotide.